A Study of ALKS 4230 (Nemvaleukin Alfa) With Pembrolizumab in Head and Neck Cancer

计划入组 14 人 · 首次发布于 2019 年 10 月 30 日

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

计划入组 173 人 · 首次发布于 2021 年 4 月 2 日

A Study of the Effects of ALKS 4230 (Nemvaleukin Alfa) on Subjects With Solid Tumors

计划入组 243 人 · 首次发布于 2016 年 6 月 14 日

Nemvaleukin alfa

Mural Therapeutics Discontinues Nemvaleukin Program and Cuts 90% of Workforce Following Clinical Setback

Nemvaleukin Alfa Shows Durable Antitumor Activity in Advanced Melanoma and Renal Cell Carcinoma

Nemvaleukin Shows Promising Antitumor Activity in Advanced Solid Tumors